Skip to main content
Figure 4 | Experimental Hematology & Oncology

Figure 4

From: Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse

Figure 4

Immune reconstitution after transplantation in terms of B cells (CD19+), cytotoxic T cells (CD3+ CD8+ ), T helper cells (CD3+ CD4+ ) and NK cells (CD56+ ). The first patient showed a sharp peak in CD8+ cells on day +104 (77 days after NK cell infusion) and the second patient showed the same phenomenon on day +49 (48 days after NK cell infusion), followed by a peak in NK cells. The first patient may also have had the NK peak, but it was possibly missed due to wider monitoring intervals. The peaks could not be correlated with clinical events.

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us